California 2019-2020 Regular Session

California Assembly Bill AB1419

Introduced
2/22/19  
Introduced
2/22/19  
Refer
3/28/19  
Refer
3/28/19  
Report Pass
3/28/19  
Report Pass
3/28/19  
Refer
4/1/19  
Refer
4/1/19  
Failed
2/3/20  

Caption

Medical waste: pharmaceuticals.

Impact

If enacted, AB 1419 will alter the current definitions and regulations pertaining to medical waste, particularly affecting how pharmaceutical waste is categorized and managed. The proposed amendments include removing certain herbal and cosmetic products from the pharmaceutical waste category, which may ease disposal procedures for healthcare providers and pharmacies. This could potentially simplify compliance and promote more efficient waste management practices within California's healthcare system.

Summary

Assembly Bill 1419 aims to amend sections of the Government Code and the Health and Safety Code concerning the management and disposal of medical waste, particularly focusing on pharmaceutical waste. Specifically, the bill seeks to clarify what constitutes pharmaceutical waste by excluding certain products from this definition, such as herbal-based remedies, homeopathic drugs, and various cosmetic products. The intent behind this legislation is to streamline regulations and reduce unnecessary burdens on the disposal of medical waste while ensuring that public health and safety are maintained.

Sentiment

The reception of AB 1419 appears to be mixed among stakeholders. Proponents of the bill, including some healthcare professionals and regulatory bodies, argue that the changes will facilitate better waste management methods and reduce costs associated with handling pharmaceutical waste. Conversely, critics express concerns that the bill could lead to a lack of oversight in pharmaceutical waste disposal, ultimately jeopardizing public health and environmental safety. The debate underscores the tension between regulatory efficiency and safeguarding community health.

Contention

A notable point of contention within the discussions surrounding AB 1419 revolves around the balance between regulatory simplification and the need for stringent environmental protections. Opponents worry that the exclusions outlined in the bill might lead to improper disposal of medical products that can otherwise pose risks to public health and the environment. The conflict highlights the challenges lawmakers face in pursuing both economic efficiency and the safeguarding of environmental and health standards.

Companion Bills

No companion bills found.

Similar Bills

CA AB514

Registered sex offenders: day care facilities.

CA AB2277

Solid waste facilities: home-generated pharmaceutical waste: incineration.

OR SB139

Relating to infectious waste.

VA SB591

Marijuana; shape productions, definitions.

HI HB386

Relating To Controlled Substances.

CT SB01102

An Act Concerning Pharmacies And Pharmacists.

CT HB05262

An Act Concerning The Pharmacy Practice Act And Counterfeit Drugs Or Devices.

VA HB2294

Industrial hemp; regulated hemp products, etc.